The short-term effects of low-level laser therapy in the management of breast-cancer-related lymphedema.
BACKGROUND
Breast-cancer-related lymphedema (BCRL) is a chronic disease, and currently there is no definitive treatment for it. There are some therapeutic interventions targeted to decrease the limb swelling and the associated problems. Low-level laser therapy (LLLT) has been used in the treatment of post-mastectomy lymphedema since 2007 in the US. The aim of this study is to review our short-term experience with LLLT in the treatment of BCRL.


METHODS
Seventeen BCRL patients referred to our lymphedema program between 2007 and 2009 were enrolled in this study. All patients had experienced at least one conventional treatment modality such as complex physical therapy, manual lymphatic drainage, and/or pneumatic pump therapy. LLLT was added to patients' ongoing therapeutic regimen. All patients completed the full course of LLLT consisting of two cycles. The difference between sums of the circumferences of both affected and unaffected arms (ΔC), pain score, scar mobility, and range of motion were measured before and after first and second cycles of LLLT sequentially.


RESULTS
All patients were female with a median age of 51.8 (44-64) years. ΔC decreased 54% (15-85%) and 73% (33-100%), after the first and second cycles of LLLT, respectively. Fourteen out of seventeen experienced decreased pain with motion by an average of 40% (0-85%) and 62.7% (0-100%) after the first and second cycle of LLLT, respectively. Three patients had no improvement in pain after LLLT. Scar mobility increased in 13 (76.4%) and shoulder range of motion improved in 14 (82.3%) patients after LLLT. One patient developed cellulitis during LLLT.


CONCLUSIONS
Patients with BCRL received additional benefits from LLLT when used in conjunction with standard lymphedema treatment. These benefits include reduction in limb circumference, pain, increase in range of motion and scar mobility. Additionally, two cycles of LLLT were found to be superior to one in this study.
Dirican
Abuzer
A
Department of Surgery, Division of Surgical Oncology, Magee-Womens Hospital University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Andacoglu
Oya
O
Johnson
Ronald
R
McGuire
Kandace
K
Mager
Lisa
L
Soran
Atilla
A
D000328:Adult; D001132:Arm / Q000473:pathology; D001943:Breast Neoplasms / Q000150:complications* / Q000601:surgery; D002481:Cellulitis / Q000209:etiology; D002921:Cicatrix / Q000209:etiology; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D028022:Low-Level Light Therapy / Q000379:methods*; D008209:Lymphedema / Q000209:etiology / Q000532:radiotherapy* / Q000628:therapy; D008408:Mastectomy / Q000009:adverse effects* / Q000379:methods; D008875:Middle Aged; D010146:Pain / Q000209:etiology; D016059:Range of Motion, Articular; D020069:Shoulder Pain / Q000503:physiopathology; D016896:Treatment Outcome
Aust J Physiother. 2001;47(4):289-94
11722295
Clin Rehabil. 2009 Feb;23(2):117-24
19164399
Breast J. 2006 Nov-Dec;12(6):536-43
17238983
Lasers Med Sci. 2006 Jul;21(2):90-4
16673054
J Clin Nurs. 2005 Aug;14(7):798-804
16000093
Lymphology. 1998 Jun;31(2):74-86
9664272
CMAJ. 2001 Jan 23;164(2):191-9
11332311
Circulation. 1992 Mar;85(3):1189-96
1537115
Cancer. 2003 Sep 15;98(6):1114-22
12973834
Am J Clin Oncol. 2003 Jun;26(3):229-31
12796589
Disabil Rehabil. 2009;31(25):2055-63
19888834
Dermatol Surg. 2003 Jan;29(1):65-73; discussion 73
12534515
Photomed Laser Surg. 2009 Oct;27(5):763-9
19878027
Cancer. 1998 Dec 15;83(12 Suppl American):2776-81
9874397
Cancer. 2000 Feb 1;88(3):608-14
10649254
Ann Oncol. 2007 Apr;18(4):639-46
17018707
Lasers Surg Med. 1993;13(4):463-9
8366747
Swiss Med Wkly. 2007 Jun 16;137(23-24):347-52
17629805
Lasers Surg Med. 2003;32(3):233-8
12605431